These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 16309576
1. Dehydroleucodine inhibits vascular smooth muscle cell proliferation in G2 phase. Cruzado M, Castro C, Fernandez D, Gomez L, Roque M, Giordano OE, Lopez LA. Cell Mol Biol (Noisy-le-grand); 2005 Nov 08; 51(6):525-30. PubMed ID: 16309576 [Abstract] [Full Text] [Related]
2. 11,13-dihydro-dehydroleucodine, a derivative of dehydroleucodine with an inactivated alkylating function conserves the anti-proliferative activity in G2 but does not cause cytotoxicity. Polo LM, Castro CM, Cruzado MC, Collino CJ, Cuello-Carrión FD, Ciocca DR, Giordano OS, Ferrari M, López LA. Eur J Pharmacol; 2007 Feb 05; 556(1-3):19-26. PubMed ID: 17134695 [Abstract] [Full Text] [Related]
3. [Tanshinone II A inhibits in vitro cellular proliferation and migration of vascular smooth muscle cell of rabbit]. Zhang HH, Chen YC, Liang L, Zeng Z. Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar 05; 39(2):188-92. PubMed ID: 18630680 [Abstract] [Full Text] [Related]
4. RNA interference targeting ORC1 gene suppresses the proliferation of vascular smooth muscle cells in rats. Shu MQ, Qin YL, Jiang MH. Exp Mol Pathol; 2008 Jun 05; 84(3):206-12. PubMed ID: 18499104 [Abstract] [Full Text] [Related]
9. Effects of oxidized low density lipoprotein on the growth of human artery smooth muscle cells. Zhao GF, Seng JJ, Zhang H, She MP. Chin Med J (Engl); 2005 Dec 05; 118(23):1973-8. PubMed ID: 16336833 [Abstract] [Full Text] [Related]
10. Inhibition of human pulmonary artery smooth muscle cell proliferation and migration by sabiporide, a new specific NHE-1 inhibitor. Wu D, Doods H, Stassen JM. J Cardiovasc Pharmacol; 2006 Aug 05; 48(2):34-40. PubMed ID: 16954819 [Abstract] [Full Text] [Related]
11. Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells. Odenlund M, Holmqvist B, Baldetorp B, Hellstrand P, Nilsson BO. Amino Acids; 2009 Feb 05; 36(2):273-82. PubMed ID: 18368465 [Abstract] [Full Text] [Related]
16. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells. Matter CM, Rozenberg I, Jaschko A, Greutert H, Kurz DJ, Wnendt S, Kuttler B, Joch H, Grünenfelder J, Zünd G, Tanner FC, Lüscher TF. J Cardiovasc Pharmacol; 2006 Dec 05; 48(6):286-92. PubMed ID: 17204907 [Abstract] [Full Text] [Related]
17. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Baskar R, Sparatore A, Del Soldato P, Moore PK. Eur J Pharmacol; 2008 Oct 10; 594(1-3):1-8. PubMed ID: 18680741 [Abstract] [Full Text] [Related]
18. Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cells. Yang Z, Cheng B, Song J, Wan Y, Wang Q, Cheng B, Chen X. Int J Cardiol; 2007 Jun 12; 118(3):381-8. PubMed ID: 17055086 [Abstract] [Full Text] [Related]
19. Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells. Lee RM, Masaki T, Yang HS, Liu J, Chen J, Li L, Blumenthal DK, Cheung AK. J Cell Biochem; 2006 Oct 15; 99(3):835-44. PubMed ID: 16721826 [Abstract] [Full Text] [Related]